This book provides guidelines to national TB program managers, policy makers, nongovernmental organizations, and donor agencies on effective management of TB. The guidelines focus on the technical and managerial aspects of treatment.
This tool estimates the risk of active tuberculosis for an individual with a tuberculin skin test reaction of 5+mm, based on his/her clinical profile. It is intended for adults tested with standard tuberculin (5 TU PPDS, or 2 TU RT-23).
This booklet calls upon national programs for TB control, donors, financing institutions, civil society, media, and communities to join hands in intensifying the fight against drug-resistant TB.
This fact sheet provides guidance to health-care providers for use of IGRAs in the diagnosis of M. tuberculosis infection in adults and children.
This report provides guidance to U.S. public health officials, health-care providers, and laboratory workers for use of FDA-approved IGRAs in the diagnosis of M. tuberculosis infection in adults and children. In brief, TSTs and IGRAs (QFT-G, QFT-GIT, and T-Spot) may be used as aids in diagnosing M. tuberculosis infection. They may be used for surveillance purposes and to identify persons likely to benefit from treatment. Multiple additional recommendations are provided that address quality control, test selection, and medical management after testing.
The ILO and WHO, with the help of other partners in the world of work, have collaborated to develop international guidelines of TB management at the workplace. These outline how any business, large or small, or public sector workplace can make a contribution to TB management and control.
This slide set was developed as an accompaniment to the guidelines Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC.
The Self-Study Modules, 1-5 is part of a series of educational modules designed to provide information about TB in a self-study format. This slide set was developed as an accompaniment to the print-based Self-Study Modules, 1-5 to aid in the presentation of module content for a facilitator-led training. The facilitator guide provides guidance and tips for leading a training using the Self-Study Modules on Tuberculosis, 1-5 Slide Sets.
This report discusses the guidelines set forth by the United States (US) Department of Health and Human Services to prevent and control the spread of tuberculosis (TB) in various types of health care facilities. The report examines the epidemiology of TB in the US, as well as the pathogenesis of TB infection to active TB. It explains the risks for the nosocomial transmission of TB, and the fundamentals of TB infection control in health-care facilities.
This new report on anti-tuberculosis (TB) drug resistance by the World Health Organization (WHO) updates “Anti-tuberculosis drug resistance in the world: Report No. 4” published by WHO in 2008. It summarizes the latest data and provides latest estimates of the global epidemic of multidrug and extensively drug-resistant tuberculosis (M/XDR-TB). For the first time, this report includes an assessment of the progress countries are making to diagnose and treat MDR-TB cases.
